Teknova Provides Strategic Business Update and Announces Preliminary Second Quarter 2024 Results

Company reaffirms 2024 revenue guidance of $35-38 million "I'm excited to share our sustained progress in executing against our strategy," said Stephen Gunstream, President and Chief Executive Officer. "I'm increasingly confident that we will continue to deliver through the end of this year and beyond, in particular as market conditions appear likely to improve, notably with recent FDA approvals of novel gene therapies and with a recovery in biotech and cell and gene therapy funding more broadly." Second qu ...